Professional
Added to YB: 2025-05-30
Pitch date: 2025-05-27
BRKR [neutral]
Bruker Corporation
+21.82%
current return
Author Info
No bio for this author
Company Info
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
Market Cap
$6.3B
Pitch Price
$37.05
Price Target
N/A
Dividend
0.48%
EV/EBITDA
13.94
P/E
-263.80
EV/Sales
2.37
Sector
Life Sciences Tools and Services
Category
value
RGA Investment Advisors Portfolio Holding: Bruker Corporation
BRKR (holding update): Life science instrumentation leader in mass spec/NMR duopoly with TMO. Trading at mid-teens P/E despite diversification since 2012 sequestration. CEO (30% owner) targeting margins to expand from 15% to mid-20s. Near-term macro challenges but growth drivers intact. Expect multiple expansion from current ~5x forward P/E.
Read full article (2 min)